Hypertension: Causes, Risk Factors, Prevention, and Management Essentials
Hypertension (HTN) – persistently elevated blood pressure ≥130/80 mmHg (ACC/AHA) or ≥140/90 mmHg (ESC/WHO) – affects ~1.3 billion adults globally. It is the leading modifiable risk factor for cardiovascular death.
Etiology and Risk Factors
Non-Modifiable
- Genetics: Heritability ~30–50%; polygenic (ACE, AGT, ADD1 variants). Family history doubles risk.
- Age: Prevalence >60% at age >60; arterial stiffening, reduced compliance.
- Race/ethnicity: Black adults: earlier onset, greater severity, higher salt sensitivity, lower renin.
- Sex: Men > women until ~65; postmenopausal women catch up (loss of estrogen protection).
Modifiable
- Obesity/overweight: BMI ≥25; visceral adiposity → RAAS activation, SNS overactivity, insulin resistance.
- High sodium / low potassium intake: Sodium >2.3 g/day; potassium <3.5 g/day.
- Physical inactivity: <150 min/week moderate activity.
- Alcohol excess: >2 drinks/day (men), >1 (women).
- Smoking/vaping: Acute BP elevation; endothelial dysfunction.
- Psychosocial stress: Chronic stress → cortisol, SNS dysregulation.
- Sleep disorders: OSA (major secondary cause), short sleep duration.
Secondary Causes (5–10% of cases)
- Renal: CKD, renal artery stenosis, glomerulonephritis.
- Endocrine: Primary aldosteronism (5–10% of HTN), Cushing's, pheochromocytoma, thyroid disease, hyperparathyroidism.
- Vascular: Coarctation of aorta.
- Drug-induced: NSAIDs, oral contraceptives, steroids, stimulants, decongestants, immunosuppressants, antidepressants (SNRIs).
Prevention Strategies
- DASH diet: Fruits, vegetables, whole grains, low-fat dairy, nuts, legumes; limits sodium, saturated fat, sugar.
- Sodium reduction: Target <1.5–2.3 g/day; greatest benefit in salt-sensitive individuals.
- Weight loss: 1 kg loss ≈ 1 mmHg BP reduction.
- Regular exercise: Aerobic 150 min/week + resistance 2×/week → ↓5–8 mmHg SBP.
- Moderate alcohol: ≤2 drinks/day (men), ≤1 (women).
- Smoking cessation.
- Stress management: Mindfulness, CBT, adequate sleep.
Diagnosis and Monitoring
- Out-of-office BP (home/ambulatory) preferred for diagnosis – avoids white-coat/masked HTN.
- Proper technique: seated 5 min, supported back/feet/arm, validated device, average ≥2 readings.
- Screen for target organ damage: ECG, echo, retinal exam, UACR, eGFR, electrolytes, lipids, glucose.
Treatment Overview
- Lifestyle first for stage 1 (130–139/80–89) without ASCVD/high risk.
- First-line meds: ACEi/ARB, CCB, thiazide/thiazide-like diuretic.
- Compelling indications: ACEi/ARB for diabetes, CKD, HFrEF; CCB for isolated systolic HTN in elderly; beta-blockers for post-MI, HF.
- Target: <130/80 for most; individualized for frail elderly, orthostatic hypotension.
Hypertension is a silent killer. Regular screening, early intervention, and sustained control prevent millions of strokes, heart attacks, and kidney failures annually.
Hypertension - Related Articles
- High Blood Pressure Ranges: Normal, Elevated & Hypertension Stages
- Alcohol and Blood Pressure: Understanding the Risks
- Natural Ways to Lower Diastolic Blood Pressure: A Comprehensive Guide
- Effective Strategies for Lowering Blood Pressure: A Comprehensive Guide
- Beta-hCG Level of 8.62 mIU/mL: What It Means
- Natural Ways to Lower Blood Pressure: A Comprehensive Guide
- Normal Blood Pressure for an 11-Month-Old Infant
